Clinical Investigative Site 3129 — Latham, New York

Clinical Investigative Site 3129 is a clinical research site located in Latham, New York, United States 12110.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Investigative Site 3129 has participated in 1 clinical trials.

Therapeutic areas: Multiple Sclerosis.

Sponsors: Actelion.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Investigative Site 3129?

Clinical Investigative Site 3129 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Investigative Site 3129 conducted?

Clinical Investigative Site 3129 has 1 clinical trials on record. Their work covers Multiple Sclerosis.

Is Clinical Investigative Site 3129 accredited by Crixeo Health?

Clinical Investigative Site 3129 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Investigative Site 3129?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.